000849980 001__ 849980
000849980 005__ 20210129234401.0
000849980 0247_ $$2doi$$a10.1016/j.cellsig.2018.06.015
000849980 0247_ $$2ISSN$$a0898-6568
000849980 0247_ $$2ISSN$$a1873-3913
000849980 0247_ $$2pmid$$apmid:29964150
000849980 0247_ $$2WOS$$aWOS:000441493100012
000849980 0247_ $$2altmetric$$aaltmetric:44598701
000849980 037__ $$aFZJ-2018-04075
000849980 082__ $$a540
000849980 1001_ $$0P:(DE-HGF)0$$aDonner, Lili$$b0
000849980 245__ $$aRelevance of N-terminal residues for amyloid-β binding to platelet integrin α IIb β 3 , integrin outside-in signaling and amyloid-β fibril formation
000849980 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2018
000849980 3367_ $$2DRIVER$$aarticle
000849980 3367_ $$2DataCite$$aOutput Types/Journal article
000849980 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1532928921_15411
000849980 3367_ $$2BibTeX$$aARTICLE
000849980 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000849980 3367_ $$00$$2EndNote$$aJournal Article
000849980 520__ $$aA pathological hallmark of Alzheimer's disease (AD) is the aggregation of amyloid-β peptides (Aβ) into fibrils, leading to deposits in cerebral parenchyma and vessels known as cerebral amyloid angiopathy (CAA). Platelets are major players of hemostasis but are also implicated in AD. Recently we provided strong evidence for a direct contribution of platelets to AD pathology. We found that monomeric Aβ40 binds through its RHDS sequence to integrin αIIbβ3, and promotes the formation of fibrillar Aβ aggregates by the secretion of adenosine diphosphate (ADP) and the chaperone protein clusterin (CLU) from platelets. Here we investigated the molecular mechanisms of Aβ binding to integrin αIIbβ3 by using Aβ11 and Aβ16 peptides. These peptides include the RHDS binding motif important for integrin binding but lack the central hydrophobic core and the C-terminal sequence of Aβ. We observed platelet adhesion to truncated N-terminal Aβ11 and Aβ16 peptides that was not mediated by integrin αIIbβ3. Thus, no integrin outside-in signaling and reduced CLU release was detected. Accordingly, platelet mediated Aβ fibril formation was not observed. Taken together, the RHDS motif of Aβ is not sufficient for Aβ binding to platelet integrin αIIbβ3 and platelet mediated Aβ fibril formation but requires other recognition or binding motifs important for platelet mediated processes in CAA. Thus, increased understanding of the molecular mechanisms of Aβ binding to platelet integrin αIIbβ3 is important to understand the role of platelets in amyloid pathology.
000849980 536__ $$0G:(DE-HGF)POF3-511$$a511 - Computational Science and Mathematical Methods (POF3-511)$$cPOF3-511$$fPOF III$$x0
000849980 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x1
000849980 536__ $$0G:(DE-HGF)POF3-341$$a341 - Molecular Signaling (POF3-341)$$cPOF3-341$$fPOF III$$x2
000849980 536__ $$0G:(DE-Juel1)hkf7_20170501$$aForschergruppe Gohlke (hkf7_20170501)$$chkf7_20170501$$fForschergruppe Gohlke$$x3
000849980 588__ $$aDataset connected to CrossRef
000849980 7001_ $$0P:(DE-Juel1)145165$$aGremer, Lothar$$b1
000849980 7001_ $$0P:(DE-Juel1)162487$$aZiehm, Tamar$$b2$$ufzj
000849980 7001_ $$0P:(DE-HGF)0$$aGertzen, Christoph G. W.$$b3
000849980 7001_ $$0P:(DE-Juel1)172663$$aGohlke, Holger$$b4$$ufzj
000849980 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b5$$ufzj
000849980 7001_ $$0P:(DE-HGF)0$$aElvers, Margitta$$b6$$eCorresponding author
000849980 773__ $$0PERI:(DE-600)1496718-2$$a10.1016/j.cellsig.2018.06.015$$gVol. 50, p. 121 - 130$$p121 - 130$$tCellular signalling$$v50$$x0898-6568$$y2018
000849980 8564_ $$uhttps://juser.fz-juelich.de/record/849980/files/1-s2.0-S0898656818301451-main.pdf$$yRestricted
000849980 8564_ $$uhttps://juser.fz-juelich.de/record/849980/files/1-s2.0-S0898656818301451-main.gif?subformat=icon$$xicon$$yRestricted
000849980 8564_ $$uhttps://juser.fz-juelich.de/record/849980/files/1-s2.0-S0898656818301451-main.pdf?subformat=pdfa$$xpdfa$$yRestricted
000849980 8564_ $$uhttps://juser.fz-juelich.de/record/849980/files/1-s2.0-S0898656818301451-main.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000849980 8564_ $$uhttps://juser.fz-juelich.de/record/849980/files/1-s2.0-S0898656818301451-main.jpg?subformat=icon-180$$xicon-180$$yRestricted
000849980 8564_ $$uhttps://juser.fz-juelich.de/record/849980/files/1-s2.0-S0898656818301451-main.jpg?subformat=icon-640$$xicon-640$$yRestricted
000849980 909CO $$ooai:juser.fz-juelich.de:849980$$pVDB
000849980 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145165$$aForschungszentrum Jülich$$b1$$kFZJ
000849980 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)162487$$aForschungszentrum Jülich$$b2$$kFZJ
000849980 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)172663$$aForschungszentrum Jülich$$b4$$kFZJ
000849980 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b5$$kFZJ
000849980 9131_ $$0G:(DE-HGF)POF3-511$$1G:(DE-HGF)POF3-510$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lSupercomputing & Big Data$$vComputational Science and Mathematical Methods$$x0
000849980 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x1
000849980 9131_ $$0G:(DE-HGF)POF3-341$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vMolecular Signaling$$x2
000849980 9141_ $$y2018
000849980 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000849980 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000849980 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000849980 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL SIGNAL : 2015
000849980 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000849980 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000849980 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000849980 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000849980 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000849980 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000849980 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000849980 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000849980 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000849980 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000849980 920__ $$lyes
000849980 9201_ $$0I:(DE-Juel1)NIC-20090406$$kNIC$$lJohn von Neumann - Institut für Computing$$x0
000849980 9201_ $$0I:(DE-Juel1)JSC-20090406$$kJSC$$lJülich Supercomputing Center$$x1
000849980 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x2
000849980 980__ $$ajournal
000849980 980__ $$aVDB
000849980 980__ $$aI:(DE-Juel1)NIC-20090406
000849980 980__ $$aI:(DE-Juel1)JSC-20090406
000849980 980__ $$aI:(DE-Juel1)ICS-6-20110106
000849980 980__ $$aUNRESTRICTED
000849980 981__ $$aI:(DE-Juel1)IBI-7-20200312